![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: AK4 |
Gene summary for AK4 |
![]() |
Gene information | Species | Human | Gene symbol | AK4 | Gene ID | 205 |
Gene name | adenylate kinase 4 | |
Gene Alias | AK 4 | |
Cytomap | 1p31.3 | |
Gene Type | protein-coding | GO ID | GO:0001666 | UniProtAcc | P27144 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
205 | AK4 | LZE4T | Human | Esophagus | ESCC | 4.01e-16 | 5.33e-01 | 0.0811 |
205 | AK4 | LZE7T | Human | Esophagus | ESCC | 2.14e-04 | 2.60e-01 | 0.0667 |
205 | AK4 | LZE8T | Human | Esophagus | ESCC | 4.28e-04 | 2.83e-01 | 0.067 |
205 | AK4 | LZE6T | Human | Esophagus | ESCC | 9.71e-04 | 4.03e-01 | 0.0845 |
205 | AK4 | P2T-E | Human | Esophagus | ESCC | 4.34e-18 | 3.41e-01 | 0.1177 |
205 | AK4 | P4T-E | Human | Esophagus | ESCC | 7.28e-15 | 5.60e-01 | 0.1323 |
205 | AK4 | P5T-E | Human | Esophagus | ESCC | 3.22e-30 | 8.02e-01 | 0.1327 |
205 | AK4 | P8T-E | Human | Esophagus | ESCC | 1.01e-03 | 5.43e-02 | 0.0889 |
205 | AK4 | P9T-E | Human | Esophagus | ESCC | 2.15e-14 | 5.86e-01 | 0.1131 |
205 | AK4 | P10T-E | Human | Esophagus | ESCC | 5.77e-20 | 5.09e-01 | 0.116 |
205 | AK4 | P11T-E | Human | Esophagus | ESCC | 4.79e-03 | 2.61e-01 | 0.1426 |
205 | AK4 | P12T-E | Human | Esophagus | ESCC | 7.34e-16 | 4.83e-01 | 0.1122 |
205 | AK4 | P15T-E | Human | Esophagus | ESCC | 5.23e-38 | 1.03e+00 | 0.1149 |
205 | AK4 | P16T-E | Human | Esophagus | ESCC | 4.98e-13 | 3.26e-01 | 0.1153 |
205 | AK4 | P17T-E | Human | Esophagus | ESCC | 4.10e-08 | 7.38e-01 | 0.1278 |
205 | AK4 | P19T-E | Human | Esophagus | ESCC | 1.65e-03 | 9.26e-01 | 0.1662 |
205 | AK4 | P20T-E | Human | Esophagus | ESCC | 3.71e-33 | 7.94e-01 | 0.1124 |
205 | AK4 | P21T-E | Human | Esophagus | ESCC | 2.13e-53 | 1.32e+00 | 0.1617 |
205 | AK4 | P22T-E | Human | Esophagus | ESCC | 1.09e-03 | 1.07e-01 | 0.1236 |
205 | AK4 | P23T-E | Human | Esophagus | ESCC | 1.88e-03 | 1.33e-01 | 0.108 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001907925 | Oral cavity | EOLP | viral genome replication | 38/2218 | 131/18723 | 9.10e-08 | 3.15e-06 | 38 |
GO:000926622 | Oral cavity | EOLP | response to temperature stimulus | 45/2218 | 178/18723 | 5.23e-07 | 1.40e-05 | 45 |
GO:000644624 | Oral cavity | EOLP | regulation of translational initiation | 25/2218 | 79/18723 | 2.47e-06 | 5.50e-05 | 25 |
GO:001714813 | Oral cavity | EOLP | negative regulation of translation | 54/2218 | 245/18723 | 4.15e-06 | 8.72e-05 | 54 |
GO:003424913 | Oral cavity | EOLP | negative regulation of cellular amide metabolic process | 58/2218 | 273/18723 | 6.23e-06 | 1.22e-04 | 58 |
GO:004677713 | Oral cavity | EOLP | protein autophosphorylation | 49/2218 | 227/18723 | 2.04e-05 | 3.21e-04 | 49 |
GO:005160721 | Oral cavity | EOLP | defense response to virus | 55/2218 | 265/18723 | 2.16e-05 | 3.35e-04 | 55 |
GO:014054621 | Oral cavity | EOLP | defense response to symbiont | 55/2218 | 265/18723 | 2.16e-05 | 3.35e-04 | 55 |
GO:000926721 | Oral cavity | EOLP | cellular response to starvation | 37/2218 | 156/18723 | 2.44e-05 | 3.62e-04 | 37 |
GO:007149625 | Oral cavity | EOLP | cellular response to external stimulus | 63/2218 | 320/18723 | 3.18e-05 | 4.49e-04 | 63 |
GO:003166823 | Oral cavity | EOLP | cellular response to extracellular stimulus | 51/2218 | 246/18723 | 4.36e-05 | 5.88e-04 | 51 |
GO:004858815 | Oral cavity | EOLP | developmental cell growth | 49/2218 | 234/18723 | 4.67e-05 | 6.20e-04 | 49 |
GO:00022633 | Oral cavity | EOLP | cell activation involved in immune response | 56/2218 | 279/18723 | 4.91e-05 | 6.47e-04 | 56 |
GO:005109021 | Oral cavity | EOLP | regulation of DNA-binding transcription factor activity | 80/2218 | 440/18723 | 5.77e-05 | 7.31e-04 | 80 |
GO:00023662 | Oral cavity | EOLP | leukocyte activation involved in immune response | 55/2218 | 275/18723 | 6.32e-05 | 7.90e-04 | 55 |
GO:00022852 | Oral cavity | EOLP | lymphocyte activation involved in immune response | 42/2218 | 194/18723 | 7.17e-05 | 8.82e-04 | 42 |
GO:004440325 | Oral cavity | EOLP | biological process involved in symbiotic interaction | 57/2218 | 290/18723 | 7.75e-05 | 9.39e-04 | 57 |
GO:004259422 | Oral cavity | EOLP | response to starvation | 42/2218 | 197/18723 | 1.03e-04 | 1.17e-03 | 42 |
GO:003166923 | Oral cavity | EOLP | cellular response to nutrient levels | 44/2218 | 215/18723 | 1.92e-04 | 1.96e-03 | 44 |
GO:004355521 | Oral cavity | EOLP | regulation of translation in response to stress | 9/2218 | 20/18723 | 2.23e-04 | 2.21e-03 | 9 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa012325 | Esophagus | ESCC | Nucleotide metabolism | 59/4205 | 85/8465 | 1.67e-04 | 6.58e-04 | 3.37e-04 | 59 |
hsa012405 | Esophagus | ESCC | Biosynthesis of cofactors | 97/4205 | 153/8465 | 3.88e-04 | 1.35e-03 | 6.94e-04 | 97 |
hsa0123212 | Esophagus | ESCC | Nucleotide metabolism | 59/4205 | 85/8465 | 1.67e-04 | 6.58e-04 | 3.37e-04 | 59 |
hsa0124012 | Esophagus | ESCC | Biosynthesis of cofactors | 97/4205 | 153/8465 | 3.88e-04 | 1.35e-03 | 6.94e-04 | 97 |
hsa01240 | Liver | Cirrhotic | Biosynthesis of cofactors | 66/2530 | 153/8465 | 3.11e-04 | 1.99e-03 | 1.23e-03 | 66 |
hsa01232 | Liver | Cirrhotic | Nucleotide metabolism | 39/2530 | 85/8465 | 1.27e-03 | 6.73e-03 | 4.15e-03 | 39 |
hsa012401 | Liver | Cirrhotic | Biosynthesis of cofactors | 66/2530 | 153/8465 | 3.11e-04 | 1.99e-03 | 1.23e-03 | 66 |
hsa012321 | Liver | Cirrhotic | Nucleotide metabolism | 39/2530 | 85/8465 | 1.27e-03 | 6.73e-03 | 4.15e-03 | 39 |
hsa012402 | Liver | HCC | Biosynthesis of cofactors | 103/4020 | 153/8465 | 4.67e-07 | 5.05e-06 | 2.81e-06 | 103 |
hsa012322 | Liver | HCC | Nucleotide metabolism | 59/4020 | 85/8465 | 3.30e-05 | 1.88e-04 | 1.04e-04 | 59 |
hsa012403 | Liver | HCC | Biosynthesis of cofactors | 103/4020 | 153/8465 | 4.67e-07 | 5.05e-06 | 2.81e-06 | 103 |
hsa012323 | Liver | HCC | Nucleotide metabolism | 59/4020 | 85/8465 | 3.30e-05 | 1.88e-04 | 1.04e-04 | 59 |
hsa012324 | Oral cavity | OSCC | Nucleotide metabolism | 54/3704 | 85/8465 | 1.78e-04 | 5.95e-04 | 3.03e-04 | 54 |
hsa012404 | Oral cavity | OSCC | Biosynthesis of cofactors | 88/3704 | 153/8465 | 3.84e-04 | 1.20e-03 | 6.12e-04 | 88 |
hsa0123211 | Oral cavity | OSCC | Nucleotide metabolism | 54/3704 | 85/8465 | 1.78e-04 | 5.95e-04 | 3.03e-04 | 54 |
hsa0124011 | Oral cavity | OSCC | Biosynthesis of cofactors | 88/3704 | 153/8465 | 3.84e-04 | 1.20e-03 | 6.12e-04 | 88 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
AK4 | SNV | Missense_Mutation | c.262G>A | p.Asp88Asn | p.D88N | P27144 | protein_coding | deleterious(0.02) | probably_damaging(0.966) | TCGA-A8-A08L-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
AK4 | SNV | Missense_Mutation | rs765366640 | c.451G>A | p.Val151Ile | p.V151I | P27144 | protein_coding | tolerated(0.66) | benign(0) | TCGA-A6-6650-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
AK4 | SNV | Missense_Mutation | rs776921061 | c.563G>A | p.Arg188Gln | p.R188Q | P27144 | protein_coding | tolerated(0.16) | benign(0.001) | TCGA-AA-3495-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
AK4 | SNV | Missense_Mutation | c.529N>A | p.Val177Met | p.V177M | P27144 | protein_coding | tolerated(0.1) | possibly_damaging(0.557) | TCGA-CM-6678-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | fluorouracil | SD | |
AK4 | SNV | Missense_Mutation | c.510N>T | p.Arg170Ser | p.R170S | P27144 | protein_coding | deleterious(0) | possibly_damaging(0.827) | TCGA-DC-6154-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | SD | |
AK4 | SNV | Missense_Mutation | rs138516264 | c.560G>A | p.Ser187Asn | p.S187N | P27144 | protein_coding | tolerated(0.2) | benign(0) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
AK4 | insertion | Frame_Shift_Ins | novel | c.664_665insAT | p.Ala222AspfsTer30 | p.A222Dfs*30 | P27144 | protein_coding | TCGA-AM-5820-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
AK4 | insertion | Nonsense_Mutation | novel | c.665_666insCTAG | p.Tyr223Ter | p.Y223* | P27144 | protein_coding | TCGA-AM-5820-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
AK4 | SNV | Missense_Mutation | novel | c.332N>T | p.Ser111Ile | p.S111I | P27144 | protein_coding | deleterious(0.03) | benign(0.316) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
AK4 | SNV | Missense_Mutation | novel | c.289G>T | p.Ala97Ser | p.A97S | P27144 | protein_coding | deleterious(0.02) | possibly_damaging(0.693) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
205 | AK4 | ENZYME, KINASE | tenofovir | TENOFOVIR | ||
205 | AK4 | ENZYME, KINASE | adefovir dipivoxil |
Page: 1 |